Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    UPC And EPO – Parallel Paths, Divergent Decisions In Pharma/biotech Patent Litigation

    The European patent landscape is evolving rapidly, particularly in the pharmaceutical/biotech sector, where the Unified Patent Court (UPC) and the European Patent Office (EPO) are shaping litigation strategies.
    IndiaIntellectual Property
    Dentons
    Dentons
  • Article

    Change In Constitution' Under The Drugs & Cosmetics Act, 1940

    While navigating through the regulatory framework governing the pharmaceutical industry in India for the purposes of deal-making, or from the perspective of running a business...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Pioneer Legal
Pioneer Legal
  • Article

    Ministries Say Yes To Data Protection

    Pursuant to the suggestions made by the inter-ministerial committee on data protection headed by Satwant Reddy, former chemicals secretary, the ministries of health and agriculture, in a recent meeting, decided to initiate action to bring amendments inserting data protection clauses in the Drugs and Cosmetics Act, 1940 and Insecticides Act, 1968
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Primer On The Uniform Code For Medical Device Marketing Practices

    The Department of Pharmaceuticals recently released the draft Uniform Code of Medical Devices Marketing Practices on March 16, 2022 to regulate the marketing of medical devices by companies in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    CDSCO's Export NOC 2.0: New Format, Tighter Checks, Faster Clearances—Are You Compliant?

    The Central Drugs Standard Control Organisation ("CDSCO") has revised the process of issuing No Objection Certificates (NOC) for the export of unapproved/approved new drugs from India as of 7th May 2025...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lexplosion Solutions Private Limited
    Lexplosion Solutions Private Limited
  • Article

    CDSCO Publishes Guidance On Medical Device Software Under MDR-2017

    The Central Drugs Standard Control Organisation (“CDSCO”) has issued the final Guidance Document on Medical Device Software under the Medical Devices Rules, 2017 (“MDR-2017”). The Guidance Document provides greater clarity on the regulation of medical device software in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    LexCounsel
    LexCounsel
  • Article

    Central Government Notifies All Implantable Devices As Drugs

    On February 08, 2019, the Central Government announced that all Implantable Medical Devices along with CT scan Equipment, MRI Equipment, Defibrillators, Dialysis Machine, PET Equipment, X-Ray Machine, and ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    E- Pharmacies- New Law To Regulate Drugs And Medical Devices

    The Electronic Commercialization of goods and services has been tremendous escalation over the past few decades.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Impact Of IPR On Pharmaceutical Industry

    Intellectual Property Rights (IPR) play a crucial role in fostering innovation and protecting the interests of creators and inventors.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    JSA Newsletter (Healthcare) - July 2022

    This edition of the JSA Healthcare Newsletter focuses on key developments undertaken in the Indian healthcare ecosystem.
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    New Drugs, Medical Devices And Cosmetics Draft Bill, 2022

    The Union Health Ministry has released a draft of The Drugs, Medical Devices and Cosmetics Bill, 2022. Once implemented, the current Drugs and Cosmetics Act, 1940...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Anand & Anand
    Anand & Anand
  • Article

    New Rules For Medical Devices

    At present, the Drugs and Cosmetics Rules, 1945 (Drugs Rules) regulate 15 categories of medical devices as drugs.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Promotion For Research And Innovation In Pharma-MedTech

    The Government of India (GoI) has focused on encouraging manufacturing in India and introducing innovative technologies.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    "SOREX Deceptively Similar To COREX"

    In the case of Pfizer Products, Inc & Anr v. Vijay Shah & Ors, the Plaintiffs, being the subsidiaries of the multinational pharmaceutical company, Pfizer Inc., had been engaged in the manufacture of an array of products including vitamin, supplements, antibiotics etc.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    The Biological Diversity (Amendment) Bill, 2023 – An Overview

    The Parliament on 1 August 2023 passed the Biological Diversity (Amendment) Bill, 2023 which amends the Biological Diversity Act, 2002.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Shardul Amarchand Mangaldas & Co
    Shardul Amarchand Mangaldas & Co
  • Article

    Patent Law Provisions Governing Research Activities Of Generic Drug Manufacturers Prior To Expiry Of Patent For Innovation Drug

    Patent tussle between generic drug manufacturers and innovation companies is commonplace in the highly competitive pharmaceuticals industry.
    IndiaIntellectual Property
    InvnTree Intellectual Property Services Pvt. Ltd.
    InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Patenting Nanotechnology Inventions – An Indian Milieu

    The current Indian patent regime fulfils nearly all the requirements of the TRIPS mandate as well as the Patent Cooperation Treaty, 1970.
    IndiaIntellectual Property
    InvnTree Intellectual Property Services Pvt. Ltd.
    InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Industry Multiples India Report : Fifth Edition

    Duff & Phelps launches the fifth edition of its Industry Multiples India report for the quarter ended September 2018.
    IndiaStrategy
    Duff and Phelps
    Duff and Phelps
  • Article

    Glenmark Pharmaceuticals Vs. Galpha Laboratories COMIP (L) No. 1063 Of 2018

    The plaintiffs highlighted that Galpha Labs has sold the impugned goods bearing the mark CLODID worth Rs 2.92 crores.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Overview Of The Drugs And Cosmetics (Tenth Amendment) Rules, 2018

    The Act and the Rules have been amended several times since coming into force to meet the need of the hour.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Showing 121–140 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics